Project ECHO®: Building Bridges in CAR T Care: Collaborative Pathways to Improve Patient Access and Navigate Referrals

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in hematologic malignancies. In this educational program, these experts discuss practical elements associated with delivering CAR T-cell therapy, including considerations for timing of referral, indications for CAR T-cell treatment, and bridging therapies, among others. Case presentations focus on identifying barriers to referral or implementation of CAR T-cell therapy, as well as potential solutions to improve access to CAR T-cell therapy in the community setting.

This educational activity is an archive of the live symposium held on June 29, 2026.

Target Audience

This educational activity is directed toward medical oncologists, hematologist-oncologists, hematologists, advanced practice providers, nurses, and other health care practitioners involved in the management of hematologic malignancies.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Apply the latest evidence to identify appropriate patients with hematologic malignancies for CAR T-cell therapy
• Implement streamlined referral processes and effective coordination with authorized treatment centers

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

PER^® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Additional Disclaimers

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.

This accredited activity has been developed in accordance with applicable accreditation standards to ensure balance, independence, objectivity, and scientific rigor. Faculty were instructed to use generic names where possible and to base recommendations on the best available evidence.

In the context of clinical discussion, proprietary product names may be mentioned. Such references are made for educational purposes only and do not constitute endorsement of any commercial product or service.

Learners are encouraged to independently evaluate the information presented and apply their own clinical judgment when considering patient care decisions.